Key facts
- This page summarizes Sophia Garnette's Form 4 filing for International Stem Cell CORP (ISCO).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 11 Jun 2021, 14:37.
Sophia Garnette - 09 Jun 2021 Form 4 Insider Report for International Stem Cell CORP (ISCO)
- Reporting relationship
- VP, Legal Affairs & Operations
- Issuer ticker
- ISCO
- Reported as of
- 09 Jun 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ Sophia Garnette
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Sophia Garnette filed Form 4 for International Stem Cell CORP (ISCO) on 11 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ISCO
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +250,000
- Change %
- Price
- $0.000000
- Shares after
- 250,000
- Date
- 09 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 250,000
- Exercise price
- $0.3900
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
3/36th of the shares underlying such options shall vest on 09/09/2021, and the remaining share in equal monthly installments over a period of 33 months.